Thyrocare Technologies Limited has informed the Exchange regarding allotment of 10,61,07,794 securities pursuant to Bonus at its meeting held on December 01, 2025
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 3.0 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Thyrocare Technologies has allotted 10,61,07,794 bonus shares (approximately 10.61 crore shares) to eligible shareholders following its board meeting on December 1, 2025. Based on the company's existing share base, this represents a generous bonus ratio, likely around 2:1 (two bonus shares for every one share held). The allotment rewards existing shareholders by increasing their share count at no extra cost to them. Shareholders who held stock on the record date will receive these additional shares credited to their demat accounts.
Positive for shareholders in terms of total shareholding value, but the stock price typically adjusts downward proportionally on the ex-bonus date, leaving overall holding value largely unchanged. No cash outflow for the company as reserves are simply converted into share capital.